These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7131483)

  • 1. New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines).
    Temple C; Wheeler GP; Elliott RD; Rose JD; Kussner CL; Comber RN; Montgomery JA
    J Med Chem; 1982 Sep; 25(9):1045-50. PubMed ID: 7131483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.
    Temple C; Wheeler GP; Elliott RD; Rose JD; Comber RN; Montgomery JA
    J Med Chem; 1983 Jan; 26(1):91-5. PubMed ID: 6827530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates.
    Temple C; Rener GA; Comber RN; Waud WR
    J Med Chem; 1991 Nov; 34(11):3176-81. PubMed ID: 1956035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of potential anticancer agents. Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines.
    Temple C; Wheeler GP; Comber RN; Elliott RD; Montgomery JA
    J Med Chem; 1983 Nov; 26(11):1614-9. PubMed ID: 6631917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamate .
    Temple C; Rener GA
    J Med Chem; 1989 Sep; 32(9):2089-92. PubMed ID: 2769680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates.
    Temple C; Rener GA
    J Med Chem; 1990 Nov; 33(11):3044-50. PubMed ID: 2231603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimitotic agents: structure-activity studies with some pyridine derivatives.
    Temple C; Rener GA; Waud WR; Noker PE
    J Med Chem; 1992 Oct; 35(20):3686-90. PubMed ID: 1433180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
    Temple C; Rose JD; Comber RN; Rener GA
    J Med Chem; 1987 Oct; 30(10):1746-51. PubMed ID: 3656351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
    Bowdon BJ; Waud WR; Wheeler GP; Hain R; Dansby L; Temple C
    Cancer Res; 1987 Mar; 47(6):1621-6. PubMed ID: 3815360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New anticancer agents: alterations of the carbamate group of ethyl (5-amino-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl)car bamates.
    Temple C; Rener GA; Comber RN
    J Med Chem; 1989 Oct; 32(10):2363-7. PubMed ID: 2795608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological effects and structure-activity relationships of 1,2-dihydropyrido[3,4-b]pyrazines.
    Wheeler GP; Bowdon BJ; Temple C; Adamson DJ; Webster J
    Cancer Res; 1983 Aug; 43(8):3567-75. PubMed ID: 6861128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamate.
    Temple C; Rener GA
    J Med Chem; 1992 Mar; 35(6):988-93. PubMed ID: 1552512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Amino-substituted 4-methyl-5H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridines: a new class of antineoplastic agents.
    Nguyen CH; Bisagni E; Pepin O; Pierré A; de Cointet P
    J Med Chem; 1987 Sep; 30(9):1642-7. PubMed ID: 3625709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compounds with presumable antitumor activity. III. 1-Substituted N,N'-di-2-pyrimidinyl (or pyrazinyl)methylenediamine].
    Chimirri A; Grasso S; Monforte P; Fenech G
    Farmaco Sci; 1984 Sep; 39(9):797-805. PubMed ID: 6500046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and antifolate activity of 5-methyl-5-deaza analogues of aminopterin, methotrexate, folic acid, and N10-methylfolic acid.
    Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Sirotnak FM
    J Med Chem; 1986 Jun; 29(6):1080-7. PubMed ID: 2423690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.
    Temple C; Rener GA
    J Med Chem; 1992 Dec; 35(26):4809-12. PubMed ID: 1479582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
    J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antineoplastic activity of phenyl-substituted benzenesulfonylhydrazones of 2-pyridinecarboxyaldehyde 1-oxide.
    Loh W; Cosby LA; Sartorelli AC
    J Med Chem; 1980 Jun; 23(6):631-4. PubMed ID: 7392030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimitotic agents: synthesis of imidazo[4,5-c]pyridin-6-ylcarbamates and imidazo[4,5-b]pyridin-5-ylcarbamates.
    Temple C
    J Med Chem; 1990 Feb; 33(2):656-61. PubMed ID: 2299631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
    Helissey P; Giorgi-Renault S; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.